- Arachidonic Acid Metabolism Pathway Is Not Only Dominant in Metabolic Modulation but Associated With Phenotypic Variation After Acute Hypoxia Exposure
Chang Liu et al, 2018, Front. Physiol. CrossRef - Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study
Xue-Fen Lei et al, 2018, WJCC CrossRef - Bioanalytical insights into the association between eicosanoids and pathogenesis of hepatocellular carcinoma
Yong-Jiang Xu et al, 2018, Cancer Metastasis Rev CrossRef - Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse prevention
Bee Luan Khoo et al, 2019, Br J Cancer CrossRef - Cyclooxygenase-2 in gastrointestinal malignancies
Ganji Purnachandra Nagaraju et al, 2019, Cancer CrossRef - Diverse perspectives to address for the future treatment of heterogeneous hepatocellular carcinoma
Atsunori Tsuchiya et al, 2019, Heliyon CrossRef - Prognostic Analysis of HCC With HCV Infection Using Epithelial-Mesenchymal Transition Gene Profiles
Masaki Ueno et al, 2020, Journal of Surgical Research CrossRef - Development of a18F-labeled Diaryl-Substituted Dihydropyrrolo[3,2,1-hi]indole as Potential Probe for Functional Imaging of Cyclooxygenase-2 with PET
Cemena Gassner et al, 2016, ChemistrySelect CrossRef - DEC1 promotes hypoxia-induced epithelial-mesenchymal transition (EMT) in human hepatocellular carcinoma cells
Keishu MURAKAMI et al, 2017, Biomed. Res. CrossRef - References
, 2017 CrossRef - Plantamajoside inhibits the proliferation and epithelial‐to‐mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia‐inducible factor‐1α‐dependent gene expression
Wenzhe Yin et al, 2020, Cell Biol Int CrossRef - The best strategy for HCC patients at each BCLC stage: a network meta-analysis of observational studies
Lei Chang et al, 2017, Oncotarget CrossRef - COX-2 induces apoptosis-resistance in hepatocellular carcinoma cells via the HIF-1α/PKM2 pathway.
Qin Wang et al, 2019, Int J Mol Med CrossRef - Mechanism for hypoxia inducible factor-1α to promote immune escape and therapeutic tolerance in hepatocellular carcinoma under hypoxic microenvironment
Huan-Zhen Yang et al, 2020, WCJD CrossRef - Prognostic value of serum HIF-1α change following transarterial chemoembolization in hepatocellular carcinoma
Zhi-Huan Lin et al, 2020, Clin Exp Med CrossRef - Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study.
Liyun Zheng et al, 2020, Front Mol Biosci CrossRef - Effects of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α overexpression on hepatocellular carcinoma survival: A systematic review with meta-analysis.
Zi-Niu Ding et al, 2021, J Gastroenterol Hepatol CrossRef - Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model
Bleuenn Brusset et al, 2021, Cancers CrossRef - Intersecting Mechanisms of Hypoxia and Prostaglandin E2-Mediated Inflammation in the Comparative Biology of Oral Squamous Cell Carcinoma
Walaa Hamed Shaker Nasry et al, 2021, Front. Oncol. CrossRef - The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition
Fernán Gómez-Valenzuela et al, 2021, Front. Oncol. CrossRef - Role of eicosanoids in liver repair, regeneration and cancer
María de Luján Alvarez et al, 2021, Biochemical Pharmacology CrossRef - HIF-2α-targeted interventional chemoembolization multifunctional microspheres for effective elimination of hepatocellular carcinoma
Minjiang Chen et al, 2022, Biomaterials CrossRef - Development and Validation of TACE Refractoriness-Related Diagnostic and Prognostic Scores and Characterization of Tumor Microenvironment Infiltration in Hepatocellular Carcinoma
Qifan He et al, 2022, Front. Immunol. CrossRef - Levosimendan Ameliorates Cardiopulmonary Function but Not Inflammatory Response in a Dual Model of Experimental ARDS
René Rissel et al, 2022, Biomedicines CrossRef - Toxic metals in the regulation of epithelial-mesenchymal plasticity: demons or angels?
Andy T. Y. Lau, 0 CrossRef - Hypoxia‑inducible factor‑1α: A critical target for inhibiting the metastasis of hepatocellular carcinoma (Review)
Huan Chen et al, 2022, Oncol Lett CrossRef - Serum alanine aminotransferase to hemoglobin ratio and radiological features predict the prognosis of postoperative adjuvant TACE in patients with hepatocellular carcinoma
Zicong Xia et al, 2022, Front. Oncol. CrossRef - A Three-Gene Signature for Predicting the Prognosis of Patients Treated with Transarterial Chemoembolization (TACE) and Identification of PD-184352 as a Potential Drug to Reverse Nonresponse to TACE
Zicong Xia et al, 2022, Journal of Oncology CrossRef - A VEGFR targeting peptide-drug conjugate (PDC) suppresses tumor angiogenesis in a TACE model for hepatocellular carcinoma therapy
Dongyuan Wang et al, 2022, Cell Death Discov. CrossRef - Proteoglycan-4 predicts good prognosis in patients with hepatocellular carcinoma receiving transcatheter arterial chemoembolization and inhibits cancer cell migration in vitro
Yuan Guo et al, 2022, Front. Oncol. CrossRef - Value of biomarkers in epithelial–mesenchymal transition models of liver cancer under different interventions: a meta-analysis
Jing Yan et al, 2023, Future Oncology CrossRef - Recent Progress in Advanced Hydrogel‐Based Embolic Agents: From Rational Design Strategies to Improved Endovascular Embolization
Xiaohong Li et al, 2023, Adv Healthcare Materials CrossRef - Hypoxia-Regulated Gene Expression and Metastasis
Ayfer Karlitepe et al, 2023 CrossRef - Targeting Hypoxia-Inducible Factor-1α for the Management of Hepatocellular Carcinoma
Kenneth N. Huynh et al, 2023, Cancers CrossRef - Norcantharidin potentiates sorafenib antitumor activity in hepatocellular carcinoma rat model through inhibiting IL-6/STAT3 pathway
Eman H. Yousef et al, 2023, Translational Research CrossRef - Hypothetical hypoxia-driven rapid disease progression in hepatocellular carcinoma post transarterial chemoembolization: A case report
Kai-Fuan Yeo et al, 2023, World J Clin Cases CrossRef - Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study
Fei Cao et al, 2023, BMC Cancer CrossRef - Efficacy and safety of tyrosine kinase inhibitors plus PD-1 inhibitor in patients with transarterial chemoembolization- refractory hepatocellular carcinoma: a two-center retrospective study
Ya Gao et al, 2023, Front. Oncol. CrossRef - Anti-cancer activity and cellular uptake of 7,3′,4′- and 7,8,4′-trihydroxyisoflavone in HepG2 cells under hypoxic conditions
Wen-Sheng Tzeng et al, 2024, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef - Molecular mechanisms of TACE refractoriness: Directions for improvement of the TACE procedure
Jiahao Li et al, 2024, Life Sciences CrossRef - Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma
Zizhuo Wang et al, 2024, Pharmaceuticals CrossRef - Assessment of using heart of date palm as a new source of protein and carbohydrate on the quality of low-fat bio fermented camel milk and its potential anticancer properties
Wael F. Elkot et al, 2024, International Journal of Biological Macromolecules CrossRef - Reprogramming of Glucose Metabolism for Revisiting Hepatocellular Carcinoma Resistance to Transcatheter Hepatic Arterial Chemoembolization
Ruijie Zhang et al, 2024, ChemBioChem CrossRef